HRYZ Biotech Co

Introduction Liver cancer is the third leading cause of cancer-related death worldwide; hepatocellular carcinoma (HCC) accounts for 90% of liver cancer (1), with a 5-year survival of 18% (2). Approximately 72% of HCC occurred in Asia, with over 50% reported in China. Hepatitis B virus infection is the leading cause of HCC, followed by alcoholic, aflatoxin, hepatitis C virus infection, and nonalcoholic fatty liver disease (3).

Shi Xie1, Rong Yan1, Anqi Zheng1, Mengfen Shi1, Longqing Tang2, XueYing Li1, Jiabang Liu1, Yifan Gan1, Yu Wang3, Deke Jiang1, Li Liu1, Hongkai Wu4 and Zhanhui Wang1* 1Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, China 2HRYZ Biotech Co., China 3Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, China 4State Key Laboratory of Respiratory...